- Home
- DRIO vs LUMO Comparison
DRIO vs LUMO Comparison
Compare DRIO & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- LUMO
- Stock Information
- Founded
- DRIO 2011
- LUMO 2011
- Country
- DRIO United States
- LUMO United States
- Employees
- DRIO N/A
- LUMO N/A
- Industry
- DRIO Medical/Dental Instruments
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- DRIO Health Care
- LUMO Health Care
- Exchange
- DRIO Nasdaq
- LUMO Nasdaq
- Market Cap
- DRIO 25.1M
- LUMO 28.8M
- IPO Year
- DRIO N/A
- LUMO N/A
- Fundamental
- Price
- DRIO $1.13
- LUMO $3.54
- Analyst Decision
- DRIO Strong Buy
- LUMO Strong Buy
- Analyst Count
- DRIO 1
- LUMO 3
- Target Price
- DRIO $4.00
- LUMO $19.00
- AVG Volume (30 Days)
- DRIO 123.1K
- LUMO 33.5K
- Earning Date
- DRIO 10-31-2024
- LUMO 11-05-2024
- Dividend Yield
- DRIO N/A
- LUMO N/A
- EPS Growth
- DRIO N/A
- LUMO N/A
- EPS
- DRIO N/A
- LUMO N/A
- Revenue
- DRIO $19,147,000.00
- LUMO $1,486,000.00
- Revenue This Year
- DRIO $36.40
- LUMO $179.77
- Revenue Next Year
- DRIO $35.93
- LUMO N/A
- P/E Ratio
- DRIO N/A
- LUMO N/A
- Revenue Growth
- DRIO N/A
- LUMO N/A
- 52 Week Low
- DRIO $0.68
- LUMO $1.37
- 52 Week High
- DRIO $3.32
- LUMO $4.55
- Technical
- Relative Strength Index (RSI)
- DRIO 62.33
- LUMO 47.20
- Support Level
- DRIO $0.95
- LUMO $3.45
- Resistance Level
- DRIO $1.16
- LUMO $3.75
- Average True Range (ATR)
- DRIO 0.09
- LUMO 0.23
- MACD
- DRIO 0.02
- LUMO -0.08
- Stochastic Oscillator
- DRIO 89.80
- LUMO 14.08
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.